Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452
IgG-Fc 融合 COVID-19 亚单位疫苗 AKS-452 的 I/II 期研究的 I 期中期结果
期刊:Vaccine
影响因子:4.5
doi:10.1016/j.vaccine.2022.01.043
Yester F Janssen, Eline A Feitsma, Hendrikus H Boersma, David G Alleva, Thomas M Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R Delpero, Melanie M Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R Haworth, Nishit J Shah, Vidhya Rao, Shashikant Nagre, Shannon E Ronca, Freedom M Gr
